|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1990-2-20
|
|
pubmed:abstractText |
The efficacy of 1.0% apraclonidine (para-aminoclonidine) in preventing the rise of intraocular pressure following anterior segment, laser surgery was evaluated in a randomised double-masked study. Ninety-nine consecutive patients requiring laser treatment of the anterior segment were included in the study. They were randomised into two groups, one receiving 1.0% para-aminoclonidine and the other placebo (vehicle of para-aminoclonidine). The drug caused a statistically significant reduction in pressure after the laser treatment without causing clinically significant side effects such as bradycardia or hypotension.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-2887153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-3062536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-3307717,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-3369999,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-3753864,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-3991124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-40089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-6387568,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-6387569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-6548856,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-6660258,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2690926-6829673
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0007-1161
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
884-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2690926-Adult,
pubmed-meshheading:2690926-Aged,
pubmed-meshheading:2690926-Anterior Eye Segment,
pubmed-meshheading:2690926-Blood Pressure,
pubmed-meshheading:2690926-Clonidine,
pubmed-meshheading:2690926-Female,
pubmed-meshheading:2690926-Heart Rate,
pubmed-meshheading:2690926-Humans,
pubmed-meshheading:2690926-Intraocular Pressure,
pubmed-meshheading:2690926-Laser Therapy,
pubmed-meshheading:2690926-Male,
pubmed-meshheading:2690926-Middle Aged,
pubmed-meshheading:2690926-Postoperative Period,
pubmed-meshheading:2690926-Prognosis,
pubmed-meshheading:2690926-Prospective Studies,
pubmed-meshheading:2690926-Randomized Controlled Trials as Topic,
pubmed-meshheading:2690926-Time Factors
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery.
|
|
pubmed:affiliation |
Vision Research Foundation, Madras, India.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
